BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37776906)

  • 1. High dose, dual-release polymeric films for extended surgical bed paclitaxel delivery.
    Mahvi DA; Korunes-Miller J; Bordeianu C; Chu NQ; Geller AD; Sabatelle R; Berry S; Hung YP; Colson YL; Grinstaff MW; Raut CP
    J Control Release; 2023 Nov; 363():682-691. PubMed ID: 37776906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy.
    Liu R; Wolinsky JB; Catalano PJ; Chirieac LR; Wagner AJ; Grinstaff MW; Colson YL; Raut CP
    Ann Surg Oncol; 2012 Jan; 19(1):199-206. PubMed ID: 21769471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films.
    Liu R; Wolinsky JB; Walpole J; Southard E; Chirieac LR; Grinstaff MW; Colson YL
    Ann Surg Oncol; 2010 Apr; 17(4):1203-13. PubMed ID: 19957041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death.
    Blessing WA; Digesu CS; Liu R; Mahvi DA; Tal-Mason A; Kumar A; Hachey KJ; Colby AH; Korunes-Miller JT; Agar N; Regan MS; Shih A; Raut CP; Grinstaff MW; Colson YL
    Mol Cancer Ther; 2022 Nov; 21(11):1663-1673. PubMed ID: 36031342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-Loaded Polymeric Meshes Prevent Local Recurrence after Sarcoma Resection While Avoiding Cardiotoxicity.
    Bressler EM; Chu NQ; Sabatelle RC; Mahvi DA; Korunes-Miller JT; Nagashima F; Ichinose F; Liu R; Grinstaff MW; Colson YL; Raut CP
    Cancer Res; 2022 Dec; 82(23):4474-4484. PubMed ID: 36169924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
    Kim SC; Kim DW; Shim YH; Bang JS; Oh HS; Wan Kim S; Seo MH
    J Control Release; 2001 May; 72(1-3):191-202. PubMed ID: 11389998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts.
    Xie M; Zhou L; Hu T; Yao M
    Anticancer Drugs; 2007 Apr; 18(4):459-66. PubMed ID: 17351398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics.
    Tsai M; Lu Z; Wientjes MG; Au JL
    J Control Release; 2013 Dec; 172(3):737-44. PubMed ID: 24056144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma.
    Garrett MC; O'Shea TM; Wollenberg AL; Bernstein AM; Hung D; Staarman B; Soto H; Deming TJ; Sofroniew MV; Kornblum HI
    PLoS One; 2020; 15(7):e0219632. PubMed ID: 32706829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stent film of paclitaxel presenting extreme accumulation of paclitaxel in tumor tissue and excellent antitumor efficacy after implantation beneath the subcutaneous tumor xenograft in mice.
    Wu K; Liu J; Lei L; Shen Y; Guo S
    Int J Pharm; 2018 Dec; 553(1-2):29-36. PubMed ID: 30267754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endosomal pH-Responsive Polymer-Based Dual-Ligand-Modified Micellar Nanoparticles for Tumor Targeted Delivery and Facilitated Intracellular Release of Paclitaxel.
    Gao Y; Zhang C; Zhou Y; Li J; Zhao L; Li Y; Liu Y; Li X
    Pharm Res; 2015 Aug; 32(8):2649-62. PubMed ID: 25676595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors.
    Lu J; Jackson JK; Gleave ME; Burt HM
    Cancer Chemother Pharmacol; 2008 May; 61(6):997-1005. PubMed ID: 17701176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
    Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
    Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
    Feng SS; Mu L; Win KY; Huang G
    Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo.
    Wang N; Wang Z; Nie S; Song L; He T; Yang S; Yang X; Yi C; Wu Q; Gong C
    Int J Nanomedicine; 2017; 12():1499-1514. PubMed ID: 28260895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of paclitaxel in patients with soft-tissue sarcoma.
    Casper ES; Waltzman RJ; Schwartz GK; Sugarman A; Pfister D; Ilson D; Woodruff J; Leung D; Bertino JR
    Cancer Invest; 1998; 16(7):442-6. PubMed ID: 9774950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.
    Swaminathan SK; Roger E; Toti U; Niu L; Ohlfest JR; Panyam J
    J Control Release; 2013 Nov; 171(3):280-7. PubMed ID: 23871962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model.
    Janát-Amsbury MM; Yockman JW; Lee M; Kern S; Furgeson DY; Bikram M; Kim SW
    Mol Ther; 2004 Jun; 9(6):829-36. PubMed ID: 15194049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts.
    Kim JH; Lee JH; Kim KS; Na K; Song SC; Lee J; Kuh HJ
    Arch Pharm Res; 2013 Jan; 36(1):94-101. PubMed ID: 23371803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
    Springate CM; Jackson JK; Gleave ME; Burt HM
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.